Role of hypoxia in the tumor microenvironment and targeted therapy

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• The tumor microenvironment (TME) in solid tumors is often characterized by hypoxia.
• Hypoxia is a critical factor influencing various tumor cell behaviors and interactions within the TME.
• Hypoxia plays a significant role in immune suppression, tumor cell metabolism, and anti-apoptotic mechanisms.

Purpose of the Study:

• To explore the molecular mechanisms by which hypoxia drives malignant tumor behavior.
• To identify novel therapeutic targets within the hypoxia-mediated pathways in the TME.
• To provide new strategies for anti-tumor therapy by understanding hypoxia's role.

Main Methods:

• Review of existing research on hypoxia's effects on tumor behavior and TME interactions.
• Analysis from the perspectives of immune cells, cell metabolism, oxidative stress, and hypoxia-inducible factor (HIF).
• Compilation of identified therapeutic targets and signaling pathways.

Main Results:

• Hypoxia influences immune cell function, cell metabolism, and oxidative stress within the TME.
• Hypoxia-inducible factor (HIF) is a key mediator of hypoxia-driven tumor progression.
• Several therapeutic targets and signaling pathways involved in hypoxia-mediated malignancy have been identified.

Conclusions:

• Understanding hypoxia's role in the TME is crucial for developing effective anti-cancer therapies.
• Targeting hypoxia-related pathways offers promising avenues for novel cancer treatments.
• Current therapies targeting hypoxia include glycolysis inhibitors, anti-angiogenesis drugs, HIF inhibitors, hypoxia-activated prodrugs, and hyperbaric medicine.